Douglas Tsao

Stock Analyst at HC Wainwright & Co.

(3.47)
# 834
Out of 4,650 analysts
439
Total ratings
45.91%
Success rate
5.15%
Average return

Stocks Rated by Douglas Tsao

Disc Medicine
Oct 28, 2024
Reiterates: Buy
Price Target: $70
Current: $45.90
Upside: +52.51%
Marinus Pharmaceuticals
Oct 25, 2024
Downgrades: Neutral
Price Target: n/a
Current: $0.29
Upside: -
Alkermes
Oct 25, 2024
Reiterates: Neutral
Price Target: $37
Current: $26.44
Upside: +39.94%
Daré Bioscience
Oct 24, 2024
Reiterates: Buy
Price Target: $12
Current: $3.96
Upside: +203.03%
Sage Therapeutics
Oct 9, 2024
Reiterates: Neutral
Price Target: $25
Current: $8.48
Upside: +194.81%
Evolus
Oct 3, 2024
Reiterates: Buy
Price Target: $27
Current: $16.69
Upside: +61.77%
Xenon Pharmaceuticals
Oct 1, 2024
Initiates: Buy
Price Target: $53
Current: $41.78
Upside: +26.85%
Neumora Therapeutics
Oct 1, 2024
Initiates: Buy
Price Target: $30
Current: $11.73
Upside: +155.75%
AEON Biopharma
Oct 1, 2024
Reiterates: Buy
Price Target: $5
Current: $0.98
Upside: +410.20%
Immunovant
Sep 30, 2024
Reiterates: Buy
Price Target: $51
Current: $29.88
Upside: +70.68%
Reiterates: Buy
Price Target: $14
Current: $5.68
Upside: +146.48%
Reiterates: Buy
Price Target: $59
Current: $50.95
Upside: +15.80%
Reiterates: Buy
Price Target: $18
Current: $11.58
Upside: +55.44%
Reiterates: Buy
Price Target: $25
Current: $4.20
Upside: +495.24%
Reiterates: Buy
Price Target: $12
Current: $0.74
Upside: +1,514.21%
Reiterates: Buy
Price Target: $15
Current: $8.65
Upside: +73.41%
Maintains: Buy
Price Target: $40$50
Current: $48.43
Upside: +3.24%
Reiterates: Buy
Price Target: $27
Current: $22.74
Upside: +18.73%
Reiterates: Buy
Price Target: $120
Current: $71.03
Upside: +68.94%
Reiterates: Buy
Price Target: $18
Current: $4.43
Upside: +306.32%
Maintains: Buy
Price Target: $11$8
Current: $3.92
Upside: +104.08%
Reiterates: Buy
Price Target: $30
Current: $5.74
Upside: +422.65%
Maintains: Buy
Price Target: $60$69
Current: $56.26
Upside: +22.64%
Maintains: Neutral
Price Target: $7$5
Current: $2.54
Upside: +96.50%
Maintains: Buy
Price Target: $92$83
Current: $27.41
Upside: +202.81%
Maintains: Buy
Price Target: $504$533
Current: $552.88
Upside: -3.60%
Maintains: Buy
Price Target: $12$11
Current: $5.91
Upside: +86.13%
Downgrades: Neutral
Price Target: $10
Current: $1.57
Upside: +536.94%
Maintains: Neutral
Price Target: $23$10
Current: $17.14
Upside: -41.66%
Maintains: Equal-Weight
Price Target: $168$182
Current: $232.40
Upside: -21.69%
Downgrades: Neutral
Price Target: $19
Current: $5.74
Upside: +226.66%
Maintains: Underweight
Price Target: $25$18
Current: $23.50
Upside: -23.40%
Initiates: Underweight
Price Target: $8
Current: $18.43
Upside: -56.59%
Initiates: Overweight
Price Target: $52
Current: $17.18
Upside: +202.68%